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Glycine receptors (GlyRs) belong to the superfamily of pentameric cys-loop receptor-
operated channels and are involved in numerous physiological functions, including
movement, vision, and pain. In search for compounds performing subunit-specific
modulation of GlyRs we studied action of ginkgolic acid, an abundant Ginkgo biloba
product. Using patch-clamp recordings, we analyzed the effects of ginkgolic acid in
concentrations from 30 nM to 25 μM on α1–α3 and α1/β, α2/β configurations of GlyR
and on GABAARs expressed in cultured CHO-K1 cells and mouse neuroblastoma
(N2a) cells. Ginkgolic acid caused an increase in the amplitude of currents mediated
by homomeric α1 and heteromeric α1/β GlyRs and provoked a left-shift of the
concentration-dependent curves for glycine. Even at high concentrations (10–25 μM)
ginkgolic acid was not able to augment ionic currents mediated by α2, α2/β, and α3
GlyRs, or by GABAAR consisting of α1/β2/γ2 subunits. Mutation of three residues
(T59A/A261G/A303S) in the α2 GlyR subunit to the corresponding ones from the α1
converted the action of ginkgolic acid to potentiation with a distinct decrease in EC50
for glycine, suggesting an important role for these residues in modulation by ginkgolic
acid. Our results suggest that ginkgolic acid is a novel selective enhancer of α1 GlyRs.
Keywords: ligand-gated channels, glycine receptor, ion currents, whole-cell recording, patch clamp, CHO cells
INTRODUCTION
Anion-selective GlyR channels provide the inhibitory drive in the vertebrate spinal cord,
brainstem, retina and some other parts of central and peripheral nervous system (Malosio et al.,
1991; Lynch, 2004; Betz and Laube, 2006). Together with cation-selective nicotinic acetylcholine
receptors and serotonin type 3 receptors, as well as with anion-selective GABAA and GABAC
receptors, they belong to the superfamily of pentameric cys-loop receptor-operated channels
(Smart and Paoletti, 2012; Lynagh and Pless, 2014).
The family of GlyRs is relatively small. Molecular cloning has enabled identiﬁcation of four
alpha subunits (α1–α4) and one beta (β) subunit with several splice variants (Laube et al.,
2002; Lynch, 2004; Oertel et al., 2007; Dutertre et al., 2012). Functional GlyRs can be either
homomeric, formed from ﬁve α subunits, or heteromeric, formed from α and β subunits with still
not deﬁnitively determined stoichiometry, suggesting either 3α/2β (Langosch et al., 1988, 1990;
Burzomato et al., 2003; Durisic et al., 2012) or 2α/3β (Grudzinska et al., 2005; Yang et al., 2012)
Abbreviations: CB receptor, cannabinoid receptor; cDNA, complementary deoxyribonucleic acid; CHO cells, Chinese
hamster ovary cells; DMSO, dimethyl sulfoxide; EC50, half-maximal concentration; GABA, γ-aminobutyric acid; GABAAR,
γ-aminobutyric acid receptor, subtypeA; GlyR, glycine receptor; Igly, glycine-induced current; THC,9-tetrahydrocannabiol;
TM, transmembrane domain; WT, wild type.
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composition. Alpha subunits are highly homologous, with
primary structures displaying 80–90% amino acid sequence
identity (Lynch, 2004); however, they diﬀer in their kinetic
properties (Takahashi et al., 1992; Singer and Berger, 1999),
temporal and regional expression (Malosio et al., 1991; Betz and
Laube, 2006; Heinze et al., 2007; Dlugaiczyk et al., 2008; Aroeira
et al., 2011) and physiological functions (Harvey et al., 2004;
Villmann et al., 2009; Dutertre et al., 2012).
Due to their diverse distribution and functions, GlyRs are
potential pharmacological targets for muscle relaxant, analgesic
and anti-inﬂammatory drugs (Webb and Lynch, 2007; Zeilhofer
et al., 2012), however, only a few compounds with preferable
subunit speciﬁcity are known (Yang et al., 2008; Lynch, 2009;
Balansa et al., 2013).
Several studies have demonstrated that ginkgolides, extracted
from the leaves of the Ginkgo biloba tree, are speciﬁc and potent
blockers of GlyR channels (Kondratskaya et al., 2002, 2004;
Hawthorne et al., 2006). Ginkgo biloba extract contains three
groups of active substances: (i) ﬂavonoid glycosides including
quercetin and rutin; (ii) terpene trilactones (ginkgolide A, B, C, J,
and bilobalide) (Ude et al., 2013); and (iii) ginkgolic acids, which
are predominantly contained in the nutshells and leaves (Jaggy
and Koch, 1997; Fuzzati et al., 2003).
It has been shown that ginkgolide B displays subtype-
selectivity, albeit weak, with about 5- and 3-fold preferences
for α1 vs. α2 and α3 GlyR subunits, respectively (Kondratskaya
et al., 2005). Moreover, the inhibitory ability of ginkgolide B
was 5- to 100-fold higher on heteromeric than on homomeric
GlyRs, i.e., incorporation of the β subunit substantially increased
the antagonism of this compound (Kondratskaya et al., 2005).
Similarly to that, the other terpen trialactones from Ginkgo
biloba extract (ginkgolide A, C, and bilobalide) block GlyR
channels though with weak subunit discrimination (Hawthorne
et al., 2006; Lynch, 2009). Quercetin, belonging to the ﬂavanoid
group, also inhibits α1 GlyR activity (Lee et al., 2008) in a
non-competitive manner, with an IC50 of about 45 μM (Raafat
et al., 2010). This compound also inhibits GABAA and GABAC
receptors (Kim et al., 2015), causing seizures in animal models
(Nassiri-Asl et al., 2014).
The functional properties of ginkgolic acid have attracted
much less attention. Ginkgo biloba extract, used in medicine, is
cleared of ginkgolic acid because of the latter’s possible side eﬀects
(Ahlemeyer et al., 2001; Hecker et al., 2002). However, it has
been shown that as long as the carboxylic acid group is intact,
either in free or in conjugated forms, no allergic manifestations
are detected (Satyan et al., 1998). Moreover, it has been suggested
that intact carboxylic acid groups are the bioactive components of
the lipophilic extract of Ginkgo biloba leaves with antidepressant
and antistress activities (Kalkunte et al., 2007). As, in contrast to
ginkgolides, the eﬀects of ginkgolic acid on the function of GlyRs
and other receptor-operated channels have not been studied,
we analyzed here the action of a speciﬁc compounds, a simple
unsaturated (R = C15:1) ginkgolic acid (Figure 1A), on GlyRs
and GABARs.
Using patch-clamp technique, we studied the eﬀects of
ginkgolic acid on ionic currents induced by activation
of receptor-operated channels expressed in CHO and
neuroblastoma cells. We have shown that ginkgolic acid causes
speciﬁc potentiation of currents mediated by α1 GlyR subunits
without strong modulation of α2, α3 GlyR, or GABAA receptors.
Moreover, three aminoacids, mutation of which transformed
the inhibitory eﬀect of ginkgolic acid into potentiation, were
identiﬁed in α2 GlyRs.
MATERIALS AND METHODS
Primary Culture and Transfection
The experiments were carried out on cultured Chinese hamster
ovary (CHO-K1) cells obtained from the American Type
Tissue Culture Collection (ATCC, Molsheim, France) and on
mouse neuroblastoma cells (N2a) cells that were maintained in
culture conditions as previously described (Waseem et al., 2010;
Mukhtarov et al., 2013).
For electrophysiological analysis cells were transfected with
cDNAs of diﬀerent receptor-operated channels. One day before
the transfection, cells were plated on the coverslips (12–14 mm
in diameter), which were placed inside 35-mm cell culture dishes
with 2 ml of medium. CHO-K1 cells were transfected with the
following cDNAs encoding GlyR subunits: human α1 (1μg/1μl),
α2 (2 μg/1 μl), α3-long (2 μg/1 μl), and β (in combination with
α1 or α2 subunits with the ratio of cDNAs concentrations 1α:5β);
or with a mixture of cDNAs encoding GABAA receptors: α1-GFP
(1 μg/μl), β2 (1 μg/μl), γ2 (1 μg/μl) using the Lipofectamine
2000 transfection protocol (Life Technology, USA). To facilitate
identiﬁcation of expressing cells, in the case of GlyR, green
ﬂuorescent protein (GFP, 0.5μg/μl) was added to the transfection
medium. Visualization of GABAAR expression was achieved by
using the α1-GFP construct (Bueno et al., 1998). Three hours
after the initial exposure of the cells to the cDNAs, a fresh solution
replaced the old one. To prevent spontaneous activation of GlyRs
by the small amount of glycine present in culture medium,
strychnine (1 μM) was added to cultures expressing all types of
GlyR subunits. Electrophysiological recordings were performed
on ﬂuorescent cells 24–72 h after transfection.
Electrophysiological Recordings
Whole-cell recordings were performed at room temperature (20–
25oC) using an EPC-9 ampliﬁer (HEKA Elektronik, Germany).
Cells were continuously superfused with external solution
containing (mM): NaCl 140, CaCl2 2, KCl 2.8, MgCl2 4, HEPES
20, glucose 10; pH 7.4; 320–330 mOsm. Two intracellular
solutions were used for ﬁlling recording patch pipettes. First,
mainly used, ‘CsCl solution’ contained (mM): CsCl 140, CaCl2 6,
MgCl2 2, MgATP 2, NaGTP 0.4, HEPES/CsOH 10, BAPTA/KOH
20; pH 7.3; 290 mOsm. In the experiments performed with CsCl
intracellular solution, ionic currents were recorded at holding
potential (Vh) –30 mV. In some experiments, ’Kgluconate
solution’ was used, in which CsCl 140 mM was replaced by
KCl 20 mM + Kgluconate 120 mM. Recordings with this
solutions were performed at Vh = 0 mV. Pipettes were pulled
from borosilicate glass capillaries (Harvard Apparatus Ltd, USA)
and had resistances of 5–10 MOhms. For rapid replacement of
solutions, the fast application system was used in this study. Two
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FIGURE 1 | Ginkgolic acid in nanomolar concentrations causes potentiation of Igly mediated by homomeric α1 GlyRs expressed in CHO cells.
(A) Structure of ginkgolic acids from G.biloba used in this study. (B) Whole-cell currents induced by 30 μM glycine in control (black trace) and at the different time
points of treatment of cells with 30 nM of ginkgolic acid (red traces). For this and subsequent figures, black bars above the traces indicate the time of agonist
application; red bars correspond to the duration of the ginkgolic acid application. Kgluconate pipette solution, holding potential (Vh) = 0 mV. (C) Examples of the
whole-cell currents induced by 30 μM glycine in control (black trace) and during application of 3 μM ginkgolic acid (red traces). Note that at this concentration
currents were already augmented 30 s after the beginning of ginkgolic acid application. Kgluconate pipette solution, Vh = 0 mV. (D) Percentage of potentiation by
100 nM ginkgolic acid (2 min of pre-application) of currents induced by 30 μM glycine for eight individual cells expressing α1 GlyRs. (E) Cumulative data on α1
GlyR-mediated current (glycine 30 μM) potentiation by 100 nM of ginkgolic acid. Mean current amplitude (pA) ± SEM from eight cells in control (black), after 2 min of
ginkgolic acid (100 nM) application (white), and after washout (striped). Paired Student’s t-test; asterisk (∗) indicates significant difference, p < 0.05.
parallel rectangular tubes (100 μm × 100 μm) were positioned
40–50 μm above the recorded cell. The movement of the tubes
was controlled by a computer-driven fast exchange system (SF
77A Perfusion Fast-Step, Warner, USA) allowing a 10–90%
solution exchange in 3–5 ms, as measured by open electrode
controls (1/10 external solution/water).
In all experiments, the duration of the pulses of agonist was
2 s. The duration of ginkgolic acid application varied from
20 s to 6 min. Cells with low input resistance (<150 MOhms)
and a rapid run-down (>30% with repetitive application) were
excluded from analysis.
Data Analysis and Statistics
All electrophysiological results were analyzed using PatchMaster
(HEKA Electronik, Germany) software. Dose–response curves
were constructed by ﬁtting values obtained at diﬀerent
concentrations, after normalization. The responses to glycine
concentration were ﬁtted using the non-linear ﬁtting routine of
the Origin 7.5 software (OriginLabs, USA) with the Hill equation:
I = 1/(1 + (EC50/[A])nH),
where I is the normalized current amplitude induced by the
agonist at concentration [A], nH is the Hill coeﬃcient and EC50
is the concentration at which a half-maximum response was
induced.
Paired and unpaired Student’s t-tests were used for statistical
analysis. The data are expressed as the means ± SEM.
Drugs
Ginkgolic acid (C15:1, HWI Analytic GmbH, Germany) was
initially dissolved in pure DMSO and then diluted with control
medium to the maximal ﬁnal concentration of DMSO 0.016%
in experiments with using 25 μM ginkgolic acid. In test
experiments, DMSO itself had no eﬀects on the Igly (data not
shown; see also Mascia et al., 1996; Hall et al., 2004).
Other drugs were obtained from Tocris or Sigma–Aldrich
(France).
RESULTS
Low Concentrations of Ginkgolic Acid
Potentiate α1 GlyRs
To examine the eﬀect of ginkgolic acid on the function of
GlyRs, whole-cell currents in CHO cells expressing diﬀerent
receptor subunits were analyzed. We ﬁrst investigated the eﬀect
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of the acid on homomeric α1 GlyRs. To cells expressing human
α1 GlyR, pulses of glycine of diﬀerent concentrations and
2-s duration were applied before, during and after addition
of ginkgolic acid. In contrast to the previously described
inhibitory action of ginkgolides (Kondratskaya et al., 2002,
2004; Hawthorne et al., 2006), ginkgolic acid at relatively
low concentrations (30 nM–3 μM) strongly enhanced whole-
cell currents induced by sub-saturating (EC10–EC50) glycine
concentrations (Figures 1 and 2). In diﬀerent cells the degree of
potentiation induced by pre-application of 100 nM ginkgolic acid
during 2 min varied from 30 to 100% (mean = 51 ± 10%, n = 8;
Figure 1D) and the average Igly increased from 291 ± 65 to
467 ± 124 (n = 8; Figure 1E).
The time course of the action of 100 nM ginkgolic acid
on currents induced by repetitive application of sub-saturating
glycine concentration is shown in Figure 2A. After obtaining
the whole-cell conﬁguration and stabilization of Igly amplitude
(ﬁrst four pulses) the external solution was changed for the one
containing 100 nM of ginkgolic acid. Following the ﬁrst 40 s,
Igly was potentiated by 54% and reached a quasi-stable level after
2 min of ginkgolic acid application (see next three pulses). Then,
after washing out for 3 min and partial recovery of Igly amplitude,
a second application of ginkgolic acid induced an even higher
and more rapidly reversible potentiation (Figure 2A). Similar
eﬀects were observed in neuroblastoma cells expressing α1 GlyR
(Figure 2B) and also in outside-out patches from CHO cells
expressing homomeric α1 GlyRs (potentiation from 25 to 290%,
n = 5, data not shown).
The kinetics of the potentiation depended on the
concentration of ginkgolic acid; the eﬀect of 30 nM ginkgolic acid
was observed after 2–3 min of treatment (Figure 1B) whereas
3 μM ginkgolic acid caused an enhancement of Igly by >30%
after only 30 s (Figure 1C). Higher concentrations of ginkgolic
acid caused even more rapid enhancement of Igly. For instance,
after 20–30 s of pre-treatment the mean potentiation induced by
25 μM ginkgolic acid was 153 ± 25% (n = 12), while 100 nM
ginkgolic acid during the same time augmented Igly by only
26 ± 8% (n = 8; data not shown).
Detailed analysis at diﬀerent glycine concentrations revealed
that ginkgolic acid potentiated currents induced by sub-
saturating doses of the agonist, while amplitudes of currents
induced by saturating concentrations of glycine (0.3–1 mM)were
not aﬀected but some acceleration of desensitization kinetics
was observed (Figure 3A). Consequently, in the presence of
ginkgolic acid, dose–response curves shifted to the left. Figure 3B
represents an example of EC50 shift from 47 μM in control to
28 μM after application of 25 μM ginkgolic acid. On average,
25 μM ginkgolic acid caused a signiﬁcant decrease in EC50 for
glycine from 36 ± 3 μM (n = 6) to 22 ± 1.4 μM (n = 6;
p < 0.01). Similar shift in EC50 was observed also at using
lower concentration of ginkgolic acid. For instance, pretreatment
of cells with 3 μM ginkgolic acid during 1–3 min caused a
signiﬁcant shift (p < 0.01) of EC50 from 36 ± 6 μM in control to
17 ± 2 μM (n = 9) after application of the acid (data not shown).
These observations demonstrate that ginkgolic acid, albeit
with slow kinetics, is capable of causing strong potentiation of
α1 GlyR even in the nanomolar range of concentrations.
Effect of Ginkgolic Acid on Heteromeric
α1/β GlyRs
Some antagonists of GlyRs exhibit diﬀerent abilities to change the
activities of homomeric and heteromeric receptors. For instance,
the plant alkaloid picrotoxin more eﬀectively inhibits homomeric
GlyR than heretomeric α/β receptors (Pribilla et al., 1992; Pistis
et al., 1997), while ginkgolide B more eﬀectively antagonizes
heteromeric GlyRs (Kondratskaya et al., 2005). To clarify whether
ginkgolic acid exhibits the homo/hetero subunit selectivity we
studied its action on heteromeric α1/β receptors.
Similarly to homomeric α1 GlyR, whole-cell currents
induced by glycine concentrations below EC50 (30 μM)
FIGURE 2 | Modulation of homomeric α1 GlyRs by ginkgolic acid. (A) Time course of the development of the effect of ginkgolic acid (100 nM) on whole-cell
currents induced by 30 μM glycine. Squares on the graph and traces above indicate amplitudes of the currents in control (black), in the presence of 100 nM of
ginkgolic acid (red) and during washout (green). Red and green bars below the graph correspond to the duration of ginkgolic acid application and washout.
Kgluconate pipette solution, Vh = 0 mV. (B) Ginkgolic acid potentiates α1 GlyRs expressed in mouse neuroblastoma (N2a) cells. Time course of Igly changes during
several application of the ginkgolic acid (3 μM) to N2a cells expressing α1 GlyR. Notice more than twofold increase in and partial recovery of Igly after the first two
applications. Kgluconate pipette solution, Vh = 0 mV.
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FIGURE 3 | Homomeric α1 and heteromeric α1/β GlyRs are similarly potentiated by ginkgolic acid. (A) Superimposed traces of whole-cell glycine-evoked
currents induced by low (10 μM; left) and high (300 μM; right) concentrations of glycine, in control (black), after ginkgolic acid application (25 μM) (red) and after
washout (green). Symmetrical CsCl pipette solution, Vh = –30 mV. (B) Ginkgolic acid causes reduction in EC50 for glycine. Representative dose–response curve for
glycine in control (black squares) and during application of 25 μM ginkgolic acid (open circles). (C) Superimposed traces of whole-cell glycine-evoked currents
induced by low (10 μM; left) and high (300 μM; right) concentrations of glycine, in control (black), after ginkgolic acid application (25 μM) (red) and after washout
(green). Recording from the cell expressing heteromeric α1/β GlyRs. Symmetrical ‘CsCl’ pipette solution, Vh = –30 mV. (D) Cumulative data. Mean percentage of
α1/β GlyR-mediated current potentiation after treatment with ginkgolic acid (25 μM).
were strongly potentiated by ginkgolic acid (Figure 3C,
left). On average, currents induced by subsaturating glycine
concentrations increased by 82 ± 39% (n = 5) in comparison
with control (Figure 3D).
Similarly to homomeric α1 GlyRs, ginkgolic acid did not
increase currents induced by application of saturated glycine
concentrations (0.3–1 mM) to heteromeric α1/β receptors
(Figure 3C, right).
Effect of Ginkgolic Acid on α2 GlyRs
Before the analysis of the action of ginkgolic acid on GlyRs
formed of α2 subunits, we estimated its EC50 by obtaining dose–
response curves. The EC50 to glycine varied from 24 to 69 μM
with a mean value 42 ± 2 μM (n = 10; data not shown), i.e.,
slightly higher than for α1 GlyRs.
In contrast to the action on α1 GlyRs, low concentrations
of ginkgolic acid (<10 μM) had no eﬀect on the amplitude
of Igly. At ginkgolic acid concentrations of 10 μM or higher,
a small inhibition of currents was observed. Thus, 10 and
25 μM of ginkgolic acid inhibited α2 GlyRs by about –
10 ± 3% (n = 8) and –20 ± 5% (n = 11), respectively
(Figure 4A). However, in many cells high doses of ginkgolic
acid stimulated non-reversible run-down, which could be an
additional reason for this small inhibition. At low concentrations
(1 μM) the eﬀect of ginkgolic acid was not detectable; with
a long application (5–6 mins) even the tendency to weak
elevation of Igly was observed. This may result partially
from a spontaneous run-up of responses during long-lasting
whole cell recordings (data not shown, but see Fucile et al.,
2000).
High concentrations of ginkgolic acid also caused a weak
inhibition of heteromeric α2/β receptors (–14 ± 4%, n = 9).
Figure 4A summarizes the action of high ginkgolic acid doses on
α2 and α2β receptors.
Effect of Ginkgolic Acid on α3 GlyRs
The human α3 GlyR subunit exists in two splice variants,
α3K (short) and α3L (long), the last one bears an additional
segment of 15 amino acids within the cytoplasmic TM3-TM4
loop (Breitinger et al., 2002) To analyze the action of ginkgolic
acid on α3 GlyRs we selected α3L splice variant as its TM3–
TM4 insert is important for spatial structure stabilization of the
cytoplasmic domain and it is involved in the regulation of GlyR
channel gating (Breitinger et al., 2009).
Analysis of concentration dependencies showed that for GlyRs
formed of this subunit the EC50 to glycine in control was
142 ± 9.8 μM (n = 11; data not shown), i.e., about threefold
higher than for α1 and α2 GlyRs.
As illustrated in Figures 4B,C, the eﬀect of ginkgolic acid
(25 μM) on the amplitude of whole-cell currents recorded from
CHO cells expressing α3 GlyR was negligible. In more detail,
after 20–40 sec of pre-treatment with ginkgolic acid, the currents
induced by a concentration of glycine ‘below EC50’ (100 μM)
slightly decreased (Figure 4B, left), on average by –9 ± 2%
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FIGURE 4 | Effect of ginkgolic acid on Igly mediated by homomeric α2 and α3 GlyRs and heteromeric α2/β GlyRs. (A) Cumulative data. Mean percentage
of the effect of 25 μM ginkgolic acid on homomeric α2 GlyRs (light gray), heteromeric α2/β GlyRs (white colomn), and 10 μM of ginkgolic acid on α2 GlyRs (striped).
Glycine 30 μM was applied. Data from 7 to 12 cells for each case. (B) Superimposed traces of glycine-evoked currents induced by low for this subunit (100 μM; left)
and high (300 μM; right) concentrations of glycine, in control (black), after ginkgolic acid application (red) and after washout (green). Symmetrical ‘CsCl’ pipette
solution, Vh = –30 mV. (C) Summary of the data on the effect of ginkgolic acid on the α3-long subunit of GlyR. Mean amplitudes of currents (pA) ± SEM induced by
100 μM glycine from six cells in control (black), during ginkgolic acid application (white), and after washout (striped).
(from –4 to –11%; n = 4); two other cells showed no eﬀect
and in one cell a weak potentiation (+4%) was observed. For
this concentration, mean currents in control, in the presence of
ginkgolic acid and after washout were, respectively, 338 ± 101
pA, 318 ± 96 pA, and 326 ± 113 pA (n = 6; Figure 4C).
Similarly to its action on α1 and α2 subunits, ginkgolic
acid accelerated the desensitization kinetics of currents induced
by application of saturated glycine concentrations (≥300 μM;
Figure 4B, right).
These data indicate that ginkgolic acid, even at high doses, is
not capable of potentiating the function of α2 and α3 GlyRs.
Effect of Ginkgolic Acid on GABAARs
We further analyzed the action of ginkgolic acid on GABA
receptors expressed in CHO cells. Its eﬀect was studied
on the most widespread in mammalian brain GABAAR
combination – α1/β2/γ2 (Olsen and Sieghart, 2008). We
assume that all cells that demonstrated GABA-evoked
currents expressed on their surface α1/β2/γ2 receptors,
as it was shown before that α1γ2, β2γ2 and homomeric
receptors are retained within the endoplasmic reticulum
(Connolly et al., 1996; Gorrie et al., 1997). Moreover, cells
transfected only with β2 subunits do not produce ionic currents
(Connolly et al., 1996) or surface staining (Taylor et al.,
1999).
Analysis of concentration dependencies revealed that the EC50
of GABA for GABAARs in control solution was 11 ± 1 μM (data
not shown). The action of ginkgolic acid was tested on 16 cells at
using concentration of GABA close to EC50 (10μM) and on three
cells using concentration of GABA close to EC10 (1 μM). After
20–40 s of treatment with ginkgolic acid (25 μM), we did not
observe any changes in GABA-evoked currents, either with EC10
(Figure 5A) or with EC50 (Figure 5B) concentrations of GABA.
For 10 μM GABA the mean currents in control, after ginkgolic
FIGURE 5 | Action of ginkgolic acid on GABA-evoked currents
recorded in CHO cells, expressing of GABAA receptors. (A,B)
Superimposed traces of currents evoked by GABA 1 μM (A) and 10 μM (B) in
control (black), after ginkgolic acid application (red) and after washout (green).
Vh = –30 mV. Symmetrical ‘CsCl’ pipette solution. (C) Summary of the data
on the effect of ginkgolic acid on α1/β2/γ2 GABARs. Mean amplitudes of
currents (pA) ± SEM induced by 10 μM GABA from 16 cells in control (black),
during ginkgolic acid application (white) and after washout (striped).
acid application and after washout were 235 ± 65 pA, 228 ± 63
pA, and 232 ± 65 pA (n = 16), respectively (Figure 5C).
Thus, similarly to the α3 GlyR, there was no signiﬁcant
diﬀerence between GABA-induced currents for the α1/β2/γ2
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combination of GABAARs before and after ginkgolic acid
(25 μM) application.
Amino Acids Involved in the Modulation
of GlyRs by Ginkgolic Acid
Finally, we searched for the residues responsible for the diﬀerent
actions of ginkgolic acid on α1 and α2 GlyR subunits. Recent
studies have identiﬁed several residues involved in allosteric
modulation of diﬀerent GlyR subunits (Xiong et al., 2011;
Yevenes and Zeilhofer, 2011a). Among them are the S296 residue
in the third TM3, as well as alanine 52 in the extracellular region
and glycine 254 in the TM2 domain.
As some parts of the chemical organization of
endocannabinoids and ginkgolic acid show high similarity
we investigated whether there are also similarities of functional
eﬀects. Indeed, both compounds produce potentiation of α1
GlyR subunits. Molecular sites for allosteric control of GlyRs
by the endocannabinoid have been identiﬁed (Yevenes and
Zeilhofer, 2011a). It has been shown that substitution in the
α2 subunit of residues T59, A261, and A303 (Figure 6A) for
corresponding residues from the α1 subunit (A52, G254, and
S296) converts the eﬀect of N-arachidonoyl–glycine from
inhibition to potentiation (Yevenes and Zeilhofer, 2011a).
In order to check whether the same amino acid residues are
indispensable for positive modulation of α1 GlyR by ginkgolic
acid we performed T59A/A261G/A303S substitution in α2
subunit (Figure 6A) and studied the eﬀect of ginkgolic acid on
currents mediated by this α2 GlyRmutant. Ginkgolic acid applied
to CHO cells expressing α2 T59A/A261G/A303S subunits caused
potentiation of responses to glycine, similar to those observed
for α1 GlyR (Figure 6B). After pre-application for 1–2 mins of
3 μM ginkgolic acid, currents induced by non-saturating glycine
concentrations (30 μM) increased in diﬀerent cells in the wide
range from 25 to 300% (Figure 6D), with a mean value of
95 ± 21% (n = 12).
Analysis of concentration dependencies revealed that the
sensitivity of the mutant GlyR to glycine was weaker than that
of WT α2 GlyR. In control conditions, the glycine EC50s for α2
mutant receptors varied from 56 to 238 μM. In the presence of
3μMginkgolic acid, dose–response curves showed a distinct left-
shift (EC50 values varied from 31 to 118 μM). Thus, in the cell
illustrated in Figure 6C, in control conditions EC50 was 157 μM
and it became 69 μM in the presence of ginkgolic acid. On
average, ginkgolic acid caused a signiﬁcant (p < 0.05) decrease
in EC50 from 119 ± 16 μM in control to 76 ± 9 μM (n = 12) in
the presence of 3 μM ginkgolic acid.
Marked potentiation was observed following the application
of ginkgolic acid in the nanomolar range of concentrations. As
illustrated in Figure 6E the time-course and amplitude of Igly
potentiation induced by 100 nM ginkgolic acid were similar to
those for α1 GlyR.
All together, these observations demonstrate that after
mutation of three residues (T59A/A261G/A303S) in the α2
FIGURE 6 | Ginkgolic acid causes potentiation of Igly on cells expressing the mutant α2 (T59A/A261G/A303S) GlyRs. (A) Primary sequence alignment of
α1 and α2 GlyR subunits in the extracellular loop, TM2 and TM3 domains; substituted residues are in red. (B) Superimposed traces of glycine-evoked currents
induced by different glycine concentrations (30, 100, 300 μM) in control (black) and after ginkgolic acid (3 μM) application (red). Kgluconate pipette solution,
Vh = 0 mV. (C) Ginkgolic acid causes a reduction in EC50 for glycine. Normalized dose–response curves for glycine in control (black squares) and during application
of 3 μM of ginkgolic acid (open circles). (D) Percentage of potentiation of glycine (30 μM) evoked currents after ginkgolic acid (3 μM) application for eight individual
cells expressing α2 (T59A/A261G/A303S) GlyRs. (E) Example of the time course of the development of the ginkgolic acid effect (3 μM) on the amplitude of the ionic
currents mediated by α2 (T59A/A261G/A303S) GlyRs; glycine 30 μM was applied. Kgluconate pipette solution, Vh = 0 mV.
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subunit the eﬀect of ginkgolic acid on the receptor became similar
to that observed on α1 GlyR.
DISCUSSION
In this study we have shown that GlyRs are modulated by
ginkgolic acid in a subunit-speciﬁc manner. After pre-application
of ginkgolic acid (0.5–6min), Igly mediated by α1GlyRs expressed
in CHO and neuroblastoma cells were strongly potentiated. This
eﬀect was observed at nanomolar ginkgolic acid concentration
(30–100 nM). High doses of ginkgolic acid (25 μM) caused
a small inhibition of α2 GlyRs, while there was no detectible
eﬀect of ginkgolic acid on amplitudes of currents mediated by α3
GlyRs or on GABAARs composed of α1/β1/γ2 subunits. These
observations indicate that low concentrations of ginkgolic acid
highly speciﬁcally potentiate α1 GlyRs.
The eﬀects of ginkgolic acid on α1 GlyRs exhibit the following
features. Firstly, potentiation is accompanied by signiﬁcant left-
shifts of dose–response curves and a decrease in EC50 values,
suggesting modulation of gating properties of α1 GlyR channels.
Analysis of dose–response curves demonstrated that 25 and 3μM
of ginkgolic acid caused a similar shift in EC50: respectively, from
36 to 22 μM and form 36 to 17 μM. This allows to suggest that
the maximal potentiation of α1 GlyR can be achieved even at
relatively low doses of the acid.
Secondly, potentiation develops slowly, on a time scale
of minutes, and the strength of the eﬀect depends on the
concentration of ginkgolic acid. During application of 30 nM
ginkgolic acid the onset of potentiation was observed only after
2–3 min, while high concentrations (25 μM) caused potentiation
by more than 150% after only 30 s of ginkgolic acid presence in
the external solution.
Recovery of glycine-evoked currents after potentiation of α1
GlyRs by ginkgolic acid, developed slowly, usually not being
complete, in the time range of minutes. This could occur for
two main reasons. First, the slow unbinding rate of ginkgolic
acid from the potentiating site of the receptor situated in a
hydrophobic membrane environment. Very low concentrations
of the drug could accumulate at binding sites and produce long-
lasting enhancement, similar to the inhibitory eﬀects of lipophilic
blockers of GlyR (Islam and Lynch, 2012). Second, spontaneous
increase in Igly, as it has been previously demonstrated that
during long-lasting whole-cell recordings the EC50 of GlyRs for
glycine spontaneously increases (Fucile et al., 2000). While this
spontaneous enhancement of currents was clearly distinguishable
from eﬀects of ginkgolic acid (Supplementary Figure S1), it
could contribute to the irreversible increase.
Ginkgolic acid at very high doses (>10 μM) caused a weak
inhibition of whole-cell currents mediated by receptors formed
of α2 subunits, without modulating the function of α3 GlyRs
and GABAAR. Moreover, at 1 μM ginkgolic acid was not able to
modulate α2 GlyRs, conﬁrming its selectivity to α1 GlyRs.
In order to further investigate this subunit-speciﬁc eﬀect of
ginkgolic acid we have focused on possible interaction sites
for this compound inside diﬀerent GlyR domains. In previous
studies it has been shown that most of the residues that are
responsible for GlyR modulation by ions, cannabinoids, alcohols,
and anesthetics are located in the extracellular domain, in the
TM2 and TM3 domains (Mihic et al., 1997; Lynch et al., 1998;
Maksay et al., 2009; Yevenes and Zeilhofer, 2011b).
It has been demonstrated that extracellularly localized amino
acid 52 of the α subunit is responsible for the diﬀerences in the
ethanol sensitivity of GlyRs composed of homomeric α1 and α2
subunits (Mascia et al., 1996). Speciﬁcally, α1 GlyRs were more
sensitive to the action of the ethanol than were α2 GlyRs or the
mutant α1 (A52S) receptors. Situated in TM3 domain, residue
S296 was found to be crucial for GlyR potentiation by THC, the
major psychoactive component of marijuana (Xiong et al., 2011).
THC more eﬀectively potentiated currents mediated by GlyR α1
subunits than the currents mediated by α2 subunits. Mutants
of α1 subunits in which serine 296 was substituted for alanine
showed a decrease in the potentiation magnitude (Xiong et al.,
2012).
Subunit-speciﬁc modulation of GlyRs has also been
demonstrated for the endocannabinoid N-arachidonoyl-glycine
and synthetic CB1 and/or CB2 receptor ligands (HU-210, WIN
55,212-2), which potentiate α1 GlyR and inhibit α2 GlyR (Yang
et al., 2008). Searching for sites involved in positive modulation
of GlyR by endocannabinoids it was revealed that substitution
of three amino acids in α2 subunits for corresponding amino
acids from α1 subunits T59A/A261G/A303S can convert the
inhibitory eﬀect of NA-Gly into potentiation (Yevenes and
Zeilhofer, 2011a). Based on the similarity of NA-Gly and
ginkgolic acid in the GlyR modulation proﬁle we have suggested
that the same amino acid residues could be responsible for α1
GlyR potentiation by ginkgolic acid.
Indeed, application of ginkgolic acid to cells expressing
α2 T59A/A261G/A303S subunits resulted in (i) an increase
in responses to low concentrations of glycine; (ii) a slow
development of the eﬀect, similarly as for α1 GlyR. This
augmentation eﬀect was observed at as low as 100 nM of ginkgolic
acid. Our results reinforce the important role of these amino acids
for speciﬁc modulation of α1 GlyR. The molecular mechanisms
underlying the interaction of drugs with these residues and
processes determining speciﬁcity of their action needs further
analysis.
In contrast to selective potentiation of alpha 1 GlyR, ginkgolic
acid caused similar acceleration of desensitization of all GlyR
subunits (see, for instance, Figures 3 and 4). In line with previous
observations (Breitinger et al., 2002) it suggests that regulation of
ion channel activation and desensitization can involve diﬀerent
domains. The molecular determinants of desensitization may
involve extracellular and TMs or interface between them (Bouzat
et al., 2008; Wang and Lynch, 2011), as well as TM1–TM2
(Breitinger et al., 2001) and TM2–TM3 (Nikolic et al., 1998;
Breitinger et al., 2002; Meiselbach et al., 2014) cytoplasmic
domains. A recent study presented compelling experimental
and modeling analysis of this phenomenon demonstrating
that the internal end of TM3 and TM1–TM2 linker control
desensitization (Gielen et al., 2015). As these parts of molecular
sequences are identical for all GlyR subunits, in a view of the
study by Gielen et al. (2015), one can suggest that regulation of
desensitization by ginkgolic acid may be developed at this level.
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Being lipophilic ginkgolic acid can penetrate plasma
membrane and interact with various intracellular targets (Fukuda
et al., 2009; Lu et al., 2012; Ma et al., 2015) causing regulation of
receptor functioning through the intracellular pathways. Thus,
activation of protein phosphatase 2C (PP2C) by ginkgolic acid
and, consequently, stimulation of neuronal death in cell cultures
has been previously demonstrated (Ahlemeyer et al., 2001).
However, ginkgolic acid caused eﬀects on PP2C at very high
concentrations (>100 μM) (Ahlemeyer et al., 2001), while the
eﬀects in our experiments eﬀects were observed at 100 nM, i.e.
1000x less concentration.
We also performed testing of ginkgolic acid action on outside-
out patches from cells expressing α1 GlyRs. This conﬁguration
should accelerate washing out of intracellular components and
eliminate potentiation. However, modulation was very similar
to that seen during whole-cell recordings. In addition, ginkgolic
acid potentiated mutant α2 GlyRs suggesting its interaction with
receptor proteins.
Although these observations reduce the assumption of
regulation through the intracellular pathways, this possibility is
not excluded. Careful analysis in a separate study using the inside-
out conﬁguration and other approaches is necessary to clarify this
question.
Several previous studies have demonstrated that cannabinoids
and endocannabinois cause modulation of GyR function
(Lozovaya et al., 2011). The most eﬀective is a natural component
of marijuana, THC, which at nanomolar concentrations
(beginning from 30 nM) caused potentiation of α1 and α3 GlyR
subunits with weak augmentation of α2 GlyR-mediated currents
(Xiong et al., 2011). However, eﬀects of other compounds from
this family are complicated, as they cause direct modulation of
voltage-gated and receptor-operated ion channels (see reviews,
Oz, 2006). While the action of gingkolic acid on other receptors,
ion channels, and synaptic networks needs future analysis, the
observations presented here suggest that this compound acts as
a speciﬁc enhancer of α1 GlyR subunits, with the threshold of
potentiation in the range of 30 nM.
A large variety of evidence indicates that GlyR subtypes are
diﬀerentially distributed in the nervous system. GlyR functions
depend on subunit composition, subsynaptic localization, and
activation mode, they are involved in the control of many motor
and sensory pathways, including those necessary for audition,
vision, respiration and nociception (Kirsch, 2006; Harvey et al.,
2009; Dutertre et al., 2012; Zeilhofer et al., 2012). Thus, α1 GlyRs
are primary localized in adult spinal cord, being responsible
for movement and muscle tone control (Kneussel and Betz,
2000; Lynch, 2004); α2 GlyRs are important for embryonic brain
development (Kneussel and Betz, 2000) and visual perception
(Haverkamp et al., 2004). These receptors are dominantly
expressed in prenatal brain, but their number dramatically
decreases between birth and the third postnatal week (Sato et al.,
1992). At the same period, the level of α1GlyRs increases and they
become widely distributed in spinal cord, retina, and brainstem
nuclei (Malosio et al., 1991; Sato et al., 1992; Greferath et al.,
1994; Zeilhofer et al., 2012). GlyRs are diﬀerentially expressed
in hippocampus and their subcellular localization and subunit
composition change over development (Aroeira et al., 2011).
Thus, our observations on subunit-speciﬁc modulation of GlyRs
by ginkgolic acid might be relevant for speciﬁc regulation of
the physiological functions mediated by GlyRs in pathological
conditions.
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